PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
5.39
+0.12 (2.28%)
At close: Sep 4, 2026, 4:00 PM EDT
5.38
-0.01 (-0.19%)
After-hours: Sep 4, 2026, 7:30 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $109.48 million as of September 4, 2026. Its market cap has increased by 101.37% in one year.
Market Cap
109.48M
Enterprise Value
104.49M
1-Year Change
101.37%
Ranking
Category
Stock Price
$5.39
ChartMarket Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $109.48M, an increase of 32.81%. That is a compound annual growth rate of 4.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 109.48M | 51.65% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genelux | 112.93M |
| Fractyl Health | 109.40M |
| Oncolytics Biotech | 109.21M |
| Seer, Inc. | 107.42M |
| RenovoRx | 106.96M |
| Coya Therapeutics | 106.73M |
| Anixa Biosciences | 103.77M |
| Tenax Therapeutics | 101.96M |